Cutler Group LP Novartis Ag Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$80.52 - $93.75 $169,414 - $197,250	2,104 New	2,104 $177,000
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $49,469 - $69,307	-700 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$84.35 - $95.37 $84,350 - $95,370	-1,000 Reduced 58.82%	700 $66,000
Q3 2019 Oct 28, 2019	BUY	$85.54 - $94.26 $119,756 - $131,964	1,400 Added 466.67%	1,700 $147,000
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $196,040 - $241,280	-2,600 Reduced 89.66%	300 $27,000
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $22,595 - $25,845	-300 Reduced 9.38%	2,900 $278,000
Q4 2018 Feb 05, 2019	BUY	$73.66 - $82.02 $117,856 - $131,232	1,600 Added 100.0%	3,200 $274,000
Q3 2018 Nov 07, 2018	BUY	$66.94 - $77.43 $107,104 - $123,888	1,600 New	1,600 $137,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.